Product and business development teams use numerous data sources to get information about drugs in the market. Orange Book from the FDA provides information about application holders, patents and exclusivity. Amongst others, the FDA also provides information about drug master filings and orphaned drugs. The Center for Medicaire and Medicaid services provides information on reimbursements and prescriptions going back many years. The problem with all this data is that it is not always clean or relatable. VisionaryRX is comprised of over 30 million rows of data from 6 different major sources. This data is then cleansed, consolidated and presented in related dashboards for research. The manual and error prone process of gathering information about a drug molecule is removed. What can be done in seconds in VisionaryRX would take days if done manually...and you'd still not get such a comprehensive view.
To facilitate collaboration and feedback we are releasing our Industry Overview Dashboard to the public. This is a high-level overview of the US pharmaceutical market. The video is a quick walkthrough on how you can use it.
VRX News & Articles
When you have access to copious amounts of data in an area people naturally ask you questions about it. I recently was introduced to an Emergency Room doctor who, upon finding out what kind of work I do, asked, “Can you see what happened to Droperidol? It was my favorite go to medication for many […]
Cloud based research consoles just released for drug companies, life science groups and the public. Minneapolis, MN, December 10, 2017: Blue Diesel Data Science LLC., a privately held data science company specializing in analytics and business intelligence, announced the beta launch of its pharmaceutical insight platform. VisionaryRX™ provides a deep and comprehensive view into the […]
November 28, 2017 Blue Diesel Data Science announces the Orphan Drug dashboard for its pharmaceutical insight tool VisionaryRX. This dashboard is designed for the identification and analysis of unique drug molecules, both designated and not designed to treat rare conditions and disease and the firms associated with them. VisionaryRX is comprised of over 50 million […]